Supplementation [topp]    
therapy [ftcn]    
Improves [qlco]    
Patients [podg]    
Chronic hepatitis C [dsyn]    
Administered [ftcn]    
Supplementation [topp]    
therapy [ftcn]    
YEARS [tmco]    
Patients [podg]    
Chronic hepatitis C [dsyn]    
Reported [inpr]    
AST [tmco]    
ALT [neop]    
Levels [qlco]    
Decreased [qnco]    
Platelet Counts [lbpr]    
Increased [qnco]    
Group [idcn]    
Increased serum zinc [fndg]    
Concentrations [menp]    
Continuing [idcn]    
treatment [ftcn]    
Clarify [acty]    
Long Term [tmco]    
consequences [ftcn]    
Report [inpr]    
serum zinc [lbpr]    
Concentrations [menp]    
Seven [qnco]    
YEARS [tmco]    
Cumulative [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
Administered [ftcn]    
Patients [podg]    
Selected [acty]    
therapy [ftcn]    
treatment [ftcn]    
Group [idcn]    
Formed [ftcn]    
Control Group [grup]    
Measured [qlco]    
serum zinc [lbpr]    
albumin concentrations [lbtr]    
Conduct [inbe]    
Study, Prospective [resa]    
Long Term [tmco]    
serum zinc [lbpr]    
Concentrations [menp]    
Seven [qnco]    
YEARS [tmco]    
mU/g [qnco]    
treatment [ftcn]    
Group [idcn]    
mU/g [qnco]    
Control Group [grup]    
Increased [qnco]    
Progression [patf]    
LIVER DISEASE [dsyn]    
depend [medd]    
Serum Albumin [aapp]    
Concentrations [menp]    
Group [idcn]    
baseline [bodm]    
Serum Albumin [aapp]    
Concentrations [menp]    
g/dL [qnco]    
serum zinc [lbpr]    
Concentrations [menp]    
Increased [qnco]    
Cumulative [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
Decrease [qlco]    
Treated [ftcn]    
Group [idcn]    
Contribute [acty]    
Reduction [npop]    
HEPATOCELLULAR CARCINOMA [neop]    
therapy [ftcn]    
Risk Ratio [qnco]    
Cl - [elii]    
Platelet Counts [lbpr]    
Supplementation [topp]    
therapy [ftcn]    
LIVER [bpoc]    
Pathology [bmod]    
HEPATOCELLULAR CARCINOMA [neop]    
